期刊文献+

2010年-2012年苏州地区新生儿先天性肾上腺皮质增生症筛查结果分析 被引量:7

Newborn screening for congenital adrenal hyperplasia in Suzhou,2010-2012
原文传递
导出
摘要 目的使先天性肾上腺皮质增生症患儿在新生儿期得到有效治疗,了解苏州地区先天性肾上腺皮质增生症的发病率。方法采用时间分辨荧光免疫分析法检测新生儿滤纸干血片上的足跟血17α-羟孕酮(17α-OHP)浓度,17α-OHP浓度大于等于切值,则重采血复查,复查值仍大于等于切值,则为疑似病例。疑似病例再测静脉血电解质、促肾上腺皮质激素、睾酮、孕酮、雌二醇进行确诊。结果 2010年9月至2012年11月共筛查南京医科大学附属苏州医院、太仓市、吴江市和昆山市新生儿96 423例,确诊先天性肾上腺皮质增生患儿5例,其中3例得到有效治疗。CAH患儿的17α-OHP水平明显高于正常新生儿的17α-OHP水平。春季和冬季新生儿17α-OHP平均水平明显高于夏季和秋季。春季、夏季、秋季和冬季新生儿17α-OHP水平的95%分位值和99%的分位值分别为(21.75,32.33),(13.31,22.50),(15.18,24.43)和(22.42,33.93)。结论 DELFIA检测17α-OHP水平能够及时筛查出失盐型和单纯男性化型患儿。苏州市新生儿CAH的发病率为1/19285。CAH筛查切值在夏季和秋季应该有所降低,而在春季和冬季应该有所提高。 Objective: To early and effectively treat the children with congenital adrenal hyperplasia (CAH) in neonatal period, and know the incidence of CAH in Suzhou area. Methods: In screening programmes, 17α - hydroxyprogesterone ( 17α - OHP) in dried blood spots obtained by a heel puncture preferably 72h after birth was measured using DELFIA. If 17α - OHP level was not lower than cut - off value, recall was needed. If the recall value was also not lower than cut - off value, the sample was defined as suspected case. Suspected eases were diagnosed by testing venous blood electrolytes, adrenocortietropic hormone, testosterone, progesterone, estradiol, combined with clinical symptorm. Results : 96 423 newborns born in Nanjing Medical University Affiliated Suzhou Hospital, Taicang city, Wujiang city and Kunshan city were screened from 2010 to 2012. Five newborns were diagnosed with the CAH, and three in five were effectively treated. The 17α - OHP level of CAII newborns is significantly higher than that of normal newborns. The 17α - OHP levels of newborns in Winter and Spring were significantly higher than that in Summer and Autumn. The percentiles 95% and 99% of four seasons are respectively (21.75, 32. 33), ( 13. 31, 22. 50), ( 15.18, 24. 43) and (22. 42, 33.93 ). Conclusions: Detecting 17α - OHP level by DELFIA can timely screen out newborns with CAH including salt wasting (SW) and simple virilizing (SV). The CAH incidence of new- borns in Suzhou City is 1/19285. The cut -off level of 17c~ -OHP in Winter and Spring is suggested to be modified.
出处 《中国优生与遗传杂志》 2013年第10期80-83,58,共5页 Chinese Journal of Birth Health & Heredity
关键词 先天性肾上腺皮质增生症 CAH 17α-羟孕酮 17α-OHP 新生儿遗传代谢病筛查 Congenital adrenal hyperplasia CAH 17α - hydroxyprogesterone 17α - OHP Neonatal screening
  • 相关文献

参考文献24

二级参考文献45

  • 1张雷,陈丽英,郭启勇.先天性肾上腺皮质增生症的影像诊断(附14例报告)[J].中国临床医学影像杂志,2005,16(2):89-91. 被引量:1
  • 2罗小平,祝婕.先天性肾上腺皮质增生症的诊断及治疗[J].实用儿科临床杂志,2006,21(8):510-512. 被引量:42
  • 3陈瑞冠.实用儿科分秘手册:第一版[M].上海科学术出版社,..
  • 4Therrell BE Jr, Berenbaum SA,Manter-Kapanke V, et al. Results of screening 1,9 million Texas newborns for 21 - hydroxylase-deficient congenital adrenal hyperplasia [ J ]. Pediatrics, 1998,101 (4) : 583 - 590.
  • 5Tajima T, Fujieda k, Nakae J, et ah Molecalar basis of nonclassical steroid 21 - hydroxylase deficiency detected by neonatal mass screening in Japan [ J ]. J Clin Endocrinol Metab, 1997,82 (5) : 2350 -2356.
  • 6Cavarzere P, Camilot M, Teofoli F, et al. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: A report three years into the program[J]. Horm Res,2005,63(4):180-186.
  • 7Van der Kamp H J, W it JM. Neonatal screening for congenital adrenal hyperplasia[ J]. Eur J Endocrinol,2004,151 (Suppl3) :U71 - U75.
  • 8Gleen HK,Wiley V,Wilcken B,et al.Tow-yearpilot Study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia[J].J Paediatr Child Health,2008,44(10):554-559.
  • 9Grunieiro-Papendieck L,Chiesa A.Mendez V,et al.Neonatal scree-ning for congenital adrenal hyperplasia:experience and results in Argentina[J].J Pediatr Endocrinol Metab,2008,21(1):71-78.
  • 10罗湘航,袁凌青.先天性肾上腺皮质增生症.见:廖二元.内分泌学[M].北京:人民卫生出版社,2007:841.

共引文献86

同被引文献75

  • 1罗小平,祝婕.先天性肾上腺皮质增生症的诊断及治疗[J].实用儿科临床杂志,2006,21(8):510-512. 被引量:42
  • 2曹敏.先天性肾上腺皮质增生症的临床若干问题[J].浙江临床医学,2006,8(7):673-674. 被引量:3
  • 3Kamisawa T,Ryu JK,Kim MH,et al.Recent advances in the diagnosis and management of autoimmune pancreatitis:similarities and differences in Japan and Korea[J].Gut Liver,2013,7:394-400.
  • 4Gleeson HK,Wiley V,Wilcken B,et al.Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia[J].J Paediatr Child Health,2008,44:554-559.
  • 5Gru(n)ieiro-Papendieck L,Chiesa A,Mendez V,et al.Neonatal screening for congenital adrenal hyperplasia:experience and results in Argentina[J].J Pediatr Endocrinol Metab,2008,21:73-78.
  • 6Morikawa S,Nakamura A,Fujikura K,et al.Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo[J].Clin Pediatr Endocrinol,2014,23:35-43.
  • 7Huet F,Godefroy A,Cheillan D,et al.Do we need congenital adrenal hyperplasia screening for premature infants?[J].Arch Pediatr,2014,21:233-236.
  • 8Gidl(o)f S,Wedell A,Guthenberg C,et al.Nationwide neonatal screening for congenital adrenal hyperplasia in sweden:a 26-year longitudinal prospective population-based study[J].JAMA Pediatr,2014,168:567-574.
  • 9Kamisawa T, Ryu JK, et al. Recent advances in the diagnosis and management of autoimmune pancreatitis :similarities and differences in Japan and Korea[J]. Gut Liver, 2013,7 (4) : 394-400.
  • 10White PC. Neonatal screening for congenital adrenal hyperplasia[J]. Nat Rev Endocrinol, 2009, 5 (9) :490-498.

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部